Novothirteen TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: inert substance, catridecacog
Pack: Novothirteen (1 x 2500 units vial, 1 x 3.2 mL inert diluent vial), 1 pack
Brand name
(ARTG)
: NOVOTHIRTEEN catridecacog (rys) 2500 IU powder for injection vial with diluent vialDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
NovoThirteen is indicated for routine prophylaxis of bleeding in patients with congenital Factor XIII A-subunit deficiency.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Injection, powder for
- Intravenous Bolus
- White lyophilised powder to be reconstituted with solvent for injection, clear glass vial
Component :
- Injection, solvent for
- Intravenous Bolus
- Clear colourless liquid in clear glass vial.
Component :
- Drug delivery system
- Intravenous
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Refrigerate
- Reconstituted Solution see indications for shelf life
- Shelf lifetime is 24 Months.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is
- 1 vial of powder for injection and one vial of diluent for resuspension with one vial adaptor pack
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
